Dialysis modalities and dyslipidemia.

  title={Dialysis modalities and dyslipidemia.},
  author={P. O. Attman and Ola Samuelsson and A C Johansson and James B. Moberly and Petar Alaupovic},
  journal={Kidney international. Supplement},
Progressive renal failure is accompanied by dyslipidemia, which is reflected in an abnormal apolipoprotein profile. It is characterized by increased concentrations of intact and partially metabolized triglyceride-rich apoB-containing lipoproteins. They occur preferentially in very-low density lipoprotein (VLDL) and low-density lipoprotein (LDL) as a result of impaired metabolism and clearance. Hemodialysis can moderately attenuate the renal dyslipidemia. In contrast, peritoneal dialysis is… CONTINUE READING